Related Experiment Video
Updated: Jul 14, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Graves' disease and its retroorbital aspects.
1Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029.
The Mount Sinai Journal of Medicine, New York
|September 1, 1992
Summary
Graves' disease, an autoimmune condition, involves unique antibodies affecting the thyroid. Eye complications require careful management to avoid worsening symptoms, suggesting targeted autoimmune therapies.
Area of Science:
- Endocrinology
- Immunology
- Ophthalmology
Background:
- Graves' disease is a common autoimmune disorder affecting the thyroid gland.
- It is characterized by autoantibodies that stimulate the thyroid-stimulating hormone (TSH) receptor.
- Ocular manifestations, known as Graves' ophthalmopathy, present unique treatment challenges.
Purpose of the Study:
- To explain the autoimmune basis of Graves' disease and its associated eye conditions.
- To highlight the risks of thyroid-destructive therapies in patients with ophthalmic involvement.
- To explore potential future therapeutic strategies targeting the autoimmune response.
Main Methods:
- Review of existing literature on Graves' disease pathogenesis.
- Analysis of the immunological mechanisms underlying thyroid and ocular involvement.
- Discussion of clinical implications for patient treatment.
Main Results:
- Graves' disease is caused by autoantibodies acting as TSH agonists.
- Destructive thyroid therapy can worsen Graves' eye disease.
- Ophthalmic disease results from immune system 'crossover specificity' for antigens in extraocular muscles, fibroblasts, and the thyroid.
Conclusions:
- Careful treatment is essential for Graves' disease patients with eye signs.
- The autoimmune response, specifically 'crossover specificity,' is implicated in ophthalmic disease.
- Targeting the autoimmune response may provide the most effective future therapy for Graves' disease and its eye complications.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...